once-weekly semaglutide in persons with obesity and knee osteoarthritis 2.4 mg Clinical Outcomes Patients or Overweight: A Real-World Retrospective Comparative Cohort Study | Advances in Therapy Semaglutide alleviates knee osteoarthritis pain

External resources PMC - Inotropic effects of retatrutide in isolated human atrial preparations ClinicalTrials.gov - Effect of Retatrutide on Cardiac Function PMC - Contractile effects of retatrutide in isolated mouse atrial preparations AHA Circulation - GLP-1 Receptor Agonists for Cardiovascular Risk Reduction In case I do not see you, good afternoon, good evening, and good night

Phase 2 results have been published in The New England Journal of Medicine

Store in a safe place out of the reach of children

All authors read and agreed to the published version of the manuscript

Summary: Ozempic (semaglutide) is not officially linked to muscle or joint pain, as musculoskeletal symptoms are not listed as recognised adverse effects in UK product information or major clinical trials